Published 11:53 IST, March 20th 2021
Cuba in final stage development of second vaccine
"Abdala" is applied in three doses, each two weeks apart. The 48,000 subjects in the Phase II trials will be between 19 and 80 years old and there will be a placebo group for control.
null | Image:
self
- Listen to this article
- 2 min read
Advertisement
11:53 IST, March 20th 2021